TCL Archive Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2 April 17, 1987
TCL Archive NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation June 12, 1992
TCL Archive DeVita Suggest Chop Should Be Expanded, Given Long Term Status, But Only With A “Quid Pro Quo” March 20, 1981
TCL Archive Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990 January 27, 1989
